
|Videos|January 27, 2015
Surgery Preperation for Individuals With ITP
Advertisement
Episodes in this series

For High-Definition, Click
Keith McCrae, MD, notes that anesthesiologists and surgeons prefer to have platelet counts around 100,000 in preparation for surgery. There are at least 3 strategies to prepare a patient with idiopathic thrombocytopenic purpura (ITP) for surgery, explains Howard A. Liebman, MD. These include infusing platelets inter-operatively, administering intravenous immunoglobulin (IVIG), or using a thrombopoietin agonist, such as romiplostim, preceding surgical intervention. In emergency surgeries, the treatment of choice, says Leibman, remains IVIG with platelets and possibly corticosteroids.
Advertisement
Related to this article

The FDA expands nogapendekin alfa inbakicept in bladder cancer, European regulators back daraxonrasib in pancreatic cancer, and more.

The FDA set a PDUFA target action date of March 31, 2027, for tabelecleucel in relapsed or refractory EBV-positive posttransplant lymphoproliferative disease.

Novel NAMPT inhibitors may circumvent the limited tolerability of previously studied agents and improve treatment outcomes in AML and MDS.

Epcoritamab plus R-CHOP reduced the risk of progression or death by 51% vs R-CHOP alone in newly diagnosed DLBCL.
Advertisement
Advertisement
Trending on OncLive
1
CHMP Recommends Approval of Daraxonrasib for Previously Treated Metastatic Pancreatic Cancer
2
Five Under 5: Top Oncology Videos for the Week of 10/12
3
Early-Phase INCA33890 Data Lay the Foundation for Phase 3 Combination Research in MSS CRC
4
VOLGA, DASL-HiCaP Data Highlight Key Genitourinary Cancer Presentations Arriving at ESMO 2026
5












